News

X-ZELL facing three start-up competition finals in one week

Singapore, November 2020 – Singapore start-up X-ZELL has been nominated for the finals of three high-profile start-up competitions and accelerator programs, all taking place within the same week from 11-18 Nov 2020. World’s Most Innovative Health Tech Start-up...

X-ZELL closes oversubscribed Seed+ round

Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world's most innovative health technology start-ups[1], X-ZELL specialises in the...

X-ZELL selected for prestigious MedTech Innovator Accelerator program

Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation specialising in medical technology and digital health,...

Next generation Cryoimmunostaining™ Suite revealed

Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite is about to receive a facelift.  According to X-ZELL’s Head of Medical Devices, Bart Van der Voort, the next generation...

X-ZELL part of Galen Growth’s 2020 HealthTech Cohort

Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across Asia. According to Julien de Salaberry, CEO &...

Essex Bio-Technology joins X-ZELL Seed+ Investment Round

Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”). Ranked amongst Asia’s 50 most innovative health technology...

X-ZELL featured in German life science magazine Laborjournal

Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications.    The extensive company profile, penned by science journalist Dr Sigrid März, outlines X-ZELL’s rapid ascent from a small Bangkok...

Interview: Krebs im Blut

Due to the overwhelming response to X-ZELL’s recent Live Sessions tour around Germany, we sat down with X-ZELL Founder & CEO, Dr Sebastian Bhakdi, to interview him in his native language.  Singapur, Februar 2020 – Der deutsche Arzt Dr. Sebastian Bhakdi (44) ist...

X-ZELL Cryoimmunostaining™ technology touring Europe

Brussels, February 2020 – Following the official European launch of X-ZELL’s Cryoimmunostaining™ Suite in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce the new technology to some of the leading minds in...

X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge

Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge.  Considered one of the world’s leading deep tech start-up competitions, the Challenge was created to celebrate the “best and...

X-ZELL

Next-generation cytology

© 2023 X-ZELL INC

Find Us

XZELL HQ